|
1
|
Budd D, Burns L, Gibson W, l'Italien G. P3‐398: Impact of access to and acceptance of diagnostic testing and outcomes in predementia Alzheimer's disease. Alzheimers Dement 2012. [DOI: 10.1016/j.jalz.2012.05.2072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- David Budd
- Bristol‐Myers SquibbPrincetonNew JerseyUnited States
| | - Leah Burns
- Bristol‐Myers SquibbLawrencevilleNew JerseyUnited States
| | | | | |
Collapse
|
|
2
|
Budd D, Nalysnyk L, Fahrbach K, Bhagwagar Z, Berman R, Burns L, l'Italien G. P2‐423: vMRI and whole‐brain volume in patients with mild‐to‐moderate Alzheimer's disease. Alzheimers Dement 2012. [DOI: 10.1016/j.jalz.2012.05.2048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- David Budd
- Bristol‐Myers SquibbPrincetonNew JerseyUnited States
| | - Luba Nalysnyk
- United BioSource CorporationLexingtonMassachusettsUnited States
| | - Kyle Fahrbach
- United BioSource CorporationMedfordMassachusettsUnited States
| | | | - Robert Berman
- Bristol‐Myers SquibbWallingfordConnecticutUnited States
| | - Leah Burns
- Bristol‐Myers SquibbLawrencevilleNew JerseyUnited States
| | | |
Collapse
|
|
3
|
Budd D, Nalysnyk L, Fahrbach K, Bhagwagar Z, Berman R, Burns L, l'Italien G. P2‐422: vMRI and hippocampal volume in patients with suspected predementia Alzheimer's disease. Alzheimers Dement 2012. [DOI: 10.1016/j.jalz.2012.05.2047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- David Budd
- Bristol‐Myers SquibbPrincetonNew JerseyUnited States
| | - Luba Nalysnyk
- United BioSource CorporationLexingtonMassachusettsUnited States
| | - Kyle Fahrbach
- United BioSource CorporationMedfordMassachusettsUnited States
| | | | - Robert Berman
- Bristol‐Myers SquibbWallingfordConnecticutUnited States
| | - Leah Burns
- Bristol‐Myers SquibbWallingfordConnecticutUnited States
| | | |
Collapse
|
|
4
|
Burns L, Rueckert D, Bhagwagar Z, Donohue M, Wolz R, Tiller J, Soares H, l'Italien G, Coric V, Hayes W, Fox N, Berman R. P2‐412: A comparison of hippocampal atrophy algorithms to select outcome measures for clinical trials in mild‐to‐moderate Alzheimer's disease. Alzheimers Dement 2012. [DOI: 10.1016/j.jalz.2012.05.2037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Leah Burns
- Bristol‐Myers SquibbLawrencevilleNew JerseyUnited States
| | | | | | - Michael Donohue
- University of CaliforniaSan Diego, La JollaCaliforniaUnited States
| | - Robin Wolz
- Imperial College LondonLondonUnited Kingdom
| | - Jane Tiller
- Bristol‐Myers SquibbPrincetonNew JerseyUnited States
| | - Holly Soares
- Bristol‐Myers SquibbPrincetonNew JerseyUnited States
| | | | - Vlad Coric
- Bristol‐Myers SquibbWallingfordConnecticutUnited States
| | - Wendy Hayes
- Bristol‐Myers SquibbPrincetonNew JerseyUnited States
| | - Nick Fox
- University College LondonLondonUnited Kingdom
| | - Robert Berman
- Bristol‐Myers SquibbWallingfordConnecticutUnited States
| |
Collapse
|